The National Technical Advisory Group on Immunisation (NTAGI) has proposed expanding the division between two quantities of Covishield vaccine to 12-16 weeks, authorities announced on Thursday, as per the statement of Press Trust of India (PTI). 

It has moreover recommended that pregnant ladies may be requested the appointment to put up with any COVID-19 vaccine and that lactating women can be vaccinated any moment after the birth.

The NTAGI possesses to stated that those retaining laboratory test proved SARS-CoV-2 disease should postpone COVID-19 vaccination for 6 months proceeding the recovery, the references explained.

Presently, the duration among 2 doses of Covishield is 4 to 8 weeks. No modification in the dosage period for Covaxin has been proposed by the committee. The suggestions of the NTAGI will be transmitted to the National Expert Group on Vaccine Adminstration for COVID-19.

READ MORE: Shortage in Vaccine, Serum Institute of India to Increase Production - Covid-19